Your encouragement has a measurable impact on your patients’ physical activity.
Gregory M. Weiss, M.D.
Drink up—but in moderation.
A reliable biomarker linked to outcomes represents another step toward the goal of individualized treatment.
An accurate, inexpensive alternative for examining smaller joints is at hand.
High-risk patients, such as older women, are most likely to benefit.
Take reports of joint crepitus seriously, especially in older patients.
Concurrent use of biologic therapies for RA and osteoporosis poses no higher risk of serious opportunistic infections.
Early intervention may prevent or delay the development of RA.
College gives patients a leg up on their less-educated neighbors.
Findings from this study may explain the “obesity paradox” for mortality in patients with RA.